[Percutaneous coronary intervention of patients with complex small coronary artery lesion unsuitable for coronary

Lang Hong1, Hong Wang, Qiu-lin Yin

  • 1Second Department of Cardiology, Jiangxi Provincial People's Hospital, Nanchang 330006, China.

Insights

Percutaneous coronary intervention (PCI) safely and effectively treats complex small coronary artery lesions in patients with low ejection fraction. This procedure improves cardiac function and long-term prognosis for heart failure patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Heart Failure Management

Background:

  • Patients with low left ventricular ejection fraction (LVEF) and complex small coronary artery lesions often have limited treatment options.
  • Coronary artery bypass grafting (CABG) may not be suitable for all patients with these complex conditions.

Purpose of the Study:

  • To evaluate the safety and efficacy of percutaneous coronary intervention (PCI) in patients with low LVEF and complex small coronary artery lesions.
  • To assess the impact of PCI on cardiac function, LVEF, and major adverse cardiac events (MACE) over a 12-month follow-up period.

Main Methods:

  • PCI revascularization was performed on 16 patients unsuitable for CABG.
  • Outcomes assessed included immediate procedural success, complications, hospitalization duration, cardiac function, LVEF, and MACE at 12 months.
  • Coronary angiography was used for re-examination at 12 months.

Main Results:

  • All PCI procedures were successful with no deaths or severe complications; hospitalization averaged 11 days.
  • At 12 months, no MACE were reported, cardiac function improved from NYHA class III-IV to I-II, and LVEF increased from 29% to 37%.
  • Left ventricular end-diastolic diameter decreased, and coronary angiography showed no intra-stent thrombosis, with restenosis in 2 cases.

Conclusions:

  • PCI is a safe and effective treatment for patients with low LVEF and complex small coronary artery lesions.
  • PCI can reduce mortality in coronary heart disease patients with heart failure.
  • The procedure improves long-term patient prognosis and cardiac function.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...